Podcasts
Podcasts
DMPK Insights #3: Free Drug Theory: No Longer Just a Hypothesis?
In this podcast, Scott Summerfield, Senior Director, Pharmaceutical Metabolism at Pharmaron discusses his recent publication on Free Drug Theory (FDT)…
Podcasts
DMPK Insights #2: Pathways to Successful Drug Design – Discovery Metabolite ID
In this podcast, Dan Weston, Scientific Leader, Biotransformation at GSK discusses his recent publication on the important role that Metabolite…
Podcasts
DMPK Insights #1: Candidate Survival – 3 Pillars to 5Rs and Beyond
In this podcast, Paul Morgan, Head of DMPK at Grünenthal Group, discusses the development of the publication that introduced the…